SightfileU.S. market data from official filings

IO BIOTECH INC (IOBTQ)

Name: IO BIOTECH INC (IOBTQ) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001865494 · EDGAR filings · Updated 2026-06-08

IO BIOTECH INC (IOBTQ) has reported institutional ownership of 4.7%, with 12 institutional managers holding positions valued at $199.0K per the latest 13F reporting period.

Institutional ownership

4.7%

Institutional managers

Reported 13F value

$199.0K

Insider activity

1 trans.

$20.9K net buying

Latest updates

2026-06-08 — 25-NSE filed
2026-06-02 — SCHEDULE 13D/A filed
2026-05-20 — SCHEDULE 13G/A filed
2026-05-15 — SCHEDULE 13G/A filed
2026-04-06 — SCHEDULE 13G/A filed
2026-03-31 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, IO BIOTECH INC has 12 institutional holders and institutional ownership of 4.7%.

Insider activity

Insiders reported 1 transactions (1 buys, 0 sells) across 1 reporting insiders, with a net reported value of $20.9K.

Related companies

BIOMERICA INC (BMRA) · InMed Pharmaceuticals Inc (INM) · VIRAX BIOLABS GROUP LTD (VRAX) · VYOME HOLDINGS INC (HIND) · Biorestorative Therapies Inc (BRTX) · ENvue Medical Inc (FEED)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-08.